APA (7th ed.) Citation

ML, T., YC, H., MY, H., JK, Y., CC, C., CY, C., . . . CY, W. (2026). Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease. Clinical epigenetics, 18(1), . https://doi.org/10.1186/s13148-026-02087-z

Chicago Style (17th ed.) Citation

ML, Tsai, et al. "Hypomethylation of VTRNA2-1 Promoter Predicts Adverse Outcomes in Peripheral Artery Disease." Clinical Epigenetics 18, no. 1 (2026). https://doi.org/10.1186/s13148-026-02087-z.

MLA (9th ed.) Citation

ML, Tsai, et al. "Hypomethylation of VTRNA2-1 Promoter Predicts Adverse Outcomes in Peripheral Artery Disease." Clinical Epigenetics, vol. 18, no. 1, 2026, https://doi.org/10.1186/s13148-026-02087-z.